Johnson & Johnson developing stem cell cure for Type 1 diabetes
Johnson & Johnson and biotech company ViaCyte are exploring a possible cure for Type 1 diabetes with encouraging results, The Associated Press reports. The stem cell treatment involves turning embryotic stem cells into insulin-producing cells in a lab, and then putting them in a small capsule to implant under a patient's skin.
Patients with Type 1 diabetes cannot produce insulin. In a healthy person, insulin is made by the body in response to rising blood sugar levels after a meal. High levels of sugar in the bloodstream can lead to the damage of blood vessels, organs, and can even kill patients. Type 1 diabetes patients need to take frequent insulin injections as a result — something the insulin-implant produced by ViaCyte and Johnson & Johnson would render unnecessary.
Testing began on patients a year ago; they received a small dose of the insulin-producing cells in their implants and are to be closely monitored for two years. The companies reported that after 12 weeks, the patient's devices were working as expected with no side effects observed. Another several rounds of patient testing are expected before regulators will approve the device.
The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.
Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
About 29.1 million Americans have diabetes, which includes 1.25 million with Type 1, or insulin-dependent, diabetes. Type 2 diabetics — whose bodies make insulin but use it ineffectively — are on the rise, as are Type 1 diabetics. Current treatment includes a strict diet, exercise, and multiple daily insulin injections and finger-prick blood tests.
-
Israel’s E1 zone in the West Bank: the death of the two-state solution?The Explainer Controversial new settlement in occupied territories makes future Palestinian state unviable, critics claim
-
What the new Making Tax Digital rules meanThe Explainer A new system will be introduced from April to overhaul how untaxed income is reported to HMRC
-
The former largest iceberg is turning blue. It’s a bad sign.Under the radar It is quickly melting away
-
Iran cuts internet as protests escalateSpeed Reada Government buildings across the country have been set on fire
-
US nabs ‘shadow’ tanker claimed by RussiaSpeed Read The ship was one of two vessels seized by the US military
-
Maduro pleads not guilty in first US court hearingSpeed Read Deposed Venezuelan leader Nicolás Maduro and his wife Cilia Flores pleaded not guilty to cocaine trafficking and narco-terrorism conspiracy
-
Iran’s government rocked by protestsSpeed Read The death toll from protests sparked by the collapse of Iran’s currency has reached at least 19
-
Israel approves new West Bank settlementsSpeed Read The ‘Israeli onslaught has all but vanquished a free Palestinian existence in the West Bank’
-
US offers Ukraine NATO-like security pact, with caveatsSpeed Read The Trump administration has offered Ukraine security guarantees similar to those it would receive from NATO
-
Hong Kong court convicts democracy advocate LaiSpeed Read Former Hong Kong media mogul Jimmy Lai was convicted in a landmark national security trial
-
Australia weighs new gun laws after antisemitic attackSpeed Read A father and son opened fire on Jewish families at Sydney’s Bondi Beach, killing at least 15
